Cases & Deals

Alizé Pharma 3 raises €67 million in financing round

Clients Alizé Pharma 3 SAS

Jones Day represented Alizé Pharma 3 SAS, a French company engaged in the research and development of new therapeutic strategies for the treatment of rare endocrine and metabolic diseases, in connection with its €67 million (US$75 million) round of financing led by LSP, and included a syndicate of international investors.